- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sai Life Sciences has allotted 403,990 new equity shares to employees following the exercise of options granted under its ESOP 2008 and MESOP 2018 plans. This strategic move strengthens employee alignment with the company's growth, as these schemes are designed to attract, retain, and reward key talent. The allotment of these fully paid-up shares, each with a Re.1 face value, results in a capital inflow of approximately INR 3.00 Crore. This expansion of the company's equity base has a proportional effect on the total outstanding shares.